Optimal risk factor management in the patient after coronary revascularization: A statement for healthcare professionals from an American Heart Association Writing Group

Circulation

Volumn 90, Issue 6, 1994, Pages 3125-3133

  Pearson, T ^a   Rapaport, E ^a   Criqui, M ^a   Furberg, C ^a   Fuster, V ^a   Hiratzka, L ^a   Little, W ^a   Ockene, I ^a   Williams, G ^a  

^a AMERICAN HEART ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT;

ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET THERAPY; FAMILY; GRAFT OCCLUSION; HEALTH ECONOMICS; HEART MUSCLE REVASCULARIZATION; HUMAN; LASER; LIPID BLOOD LEVEL; OBESITY; PHYSICAL ACTIVITY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION; SOCIAL PSYCHOLOGY; STENT; STRESS; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; WEIGHT REDUCTION;

EID: 0028641562     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.90.6.3125     Document Type: Article

References (0)